Loading…
Import this data to Google Sheets with:
=jivedata("ACRS","financials")Full statements spill as a table. For one cell: =jivedata("ACRS","Revenue") or =jivedata("ACRS","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
ACRS • CIK 0001557746
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Operating Income (Loss) | $-97,357 | $-141,932 | $-76,375 | $-86,313 |
| Net Income (Loss) Attributable to Parent | $-88,481 | $-132,065 | $-64,923 | $-75,738 |
| Weighted Average Number of Shares Outstanding, Basic | 69,808,855 | 77,296,665 | 122,564,741 | 135,890,500 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $-87,690 | $-131,862 | $-64,410 | $-76,524 |
| Revenue from Contract with Customer, Excluding Assessed Tax | $31,249 | $18,720 | $7,826 | $8,219 |
| Cost of Revenue | $3,423 | $2,792 | $2,091 | $1,683 |
| Research and Development Expense | $98,384 | $33,586 | $52,645 | $63,335 |
| General and Administrative Expense | $32,412 | $22,203 | $21,972 | $23,238 |
| Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | $-26,900 | $2,500 | $2,300 | $800 |
| Costs and Expenses | $128,606 | $160,652 | $84,201 | $94,532 |
| Investment Income, Interest | — | $7,953 | $7,637 | $6,728 |
| Royalty Income, Nonoperating | — | $1,914 | $3,815 | $3,847 |
| Nonoperating Income (Expense) | — | $9,867 | $11,452 | $10,575 |
| OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | $791 | $203 | $513 | $-786 |
| OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax | $0 | $0 | $0 | $0 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $39,878 | $24,570 | $19,960 | $19,167 |
| Debt Securities, Available-for-sale, Current | $79,228 | $89,024 | $70,791 | $72,389 |
| Debt Securities, Available-for-sale, Noncurrent | $62,771 | $90,302 | $60,612 | $79,065 |
| Property, Plant and Equipment, Net | $1,620 | $1,008 | $761 | $664 |
| Assets, Current | $128,856 | $125,951 | $96,316 | $97,765 |
| Other Assets, Noncurrent | $3,889 | $3,066 | $2,771 | $2,199 |
| Assets | $197,405 | $220,327 | $160,460 | $179,693 |
| Other Liabilities, Noncurrent | $3,074 | $4,439 | $1,565 | $1,262 |
| Contract with Customer, Liability, Noncurrent | — | $20,038 | $16,168 | $14,309 |
| Business Combination, Contingent Consideration, Liability, Noncurrent | $6,200 | $8,700 | $11,000 | $11,300 |
| Liabilities | $40,226 | $64,773 | $57,378 | $55,112 |
| Accounts Payable, Current | $8,878 | $4,690 | $13,158 | $15,516 |
| Accrued Liabilities, Current | $19,446 | $20,333 | $8,791 | $5,959 |
| Contract with Customer, Liability, Current | — | $3,890 | $3,943 | $3,976 |
| Other Liabilities, Current | — | $2,683 | $2,753 | $2,790 |
| Liabilities, Current | $30,952 | $31,596 | $28,645 | $28,241 |
| Common Stock, Value, Issued | $1 | $1 | $1 | $1 |
| Additional Paid in Capital | $928,080 | $1,058,317 | $1,070,255 | $1,133,997 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-106 | $97 | $610 | $-304 |
| Retained Earnings (Accumulated Deficit) | $-770,796 | $-902,861 | $-967,784 | $-1,009,113 |
| Stockholders' Equity Attributable to Parent | $157,179 | $155,554 | $103,082 | $124,581 |
| Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| Preferred Stock, Shares Issued | 0 | 0 | 0 | 0 |
| Common Stock, Shares Authorized | 200,000,000 | 200,000,000 | 400,000,000 | 400,000,000 |
| Common Stock, Shares, Issued | 70,894,889 | 107,850,124 | 120,499,433 | 139,824,273 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $-88,481 | $-132,065 | $-64,923 | $-75,738 |
| Net Cash Provided by (Used in) Operating Activities | $-78,325 | $-20,075 | $-47,113 | $-62,059 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $-5,399 | $-15,308 | $-4,610 | $-6,235 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $39,878 | $24,570 | $19,960 | $18,263 |
| Depreciation, Depletion and Amortization | $863 | $807 | $454 | $421 |
| Payments to Acquire Property, Plant, and Equipment | $1,309 | $121 | $111 | $118 |
| Share-based Payment Arrangement, Noncash Expense | $20,542 | $10,856 | $12,384 | $11,656 |
| Payments to Acquire Marketable Securities | $135,675 | $119,982 | $39,732 | $70,404 |
| Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | $-26,900 | $2,500 | $2,300 | $800 |
| Proceeds from Sale and Maturity of Marketable Securities | $183,204 | $86,144 | $89,041 | $74,052 |
| Payments to Acquire Intangible Assets | — | $35,810 | $35,810 | $35,810 |
| Net Cash Provided by (Used in) Investing Activities | $46,220 | $-69,769 | $48,365 | $3,530 |
| Sale of Stock, Consideration Received on Transaction | $26,714 | $74,913 | $74,913 | — |
| Payment, Tax Withholding, Share-based Payment Arrangement | $102 | $409 | $446 | $435 |
| Proceeds from Stock Options Exercised | $94 | $32 | $32 | — |
| Net Cash Provided by (Used in) Financing Activities | $26,706 | $74,536 | $-5,862 | $52,294 |
| Capital Expenditures Incurred but Not yet Paid | $24 | — | $21 | $21 |
| Increase (Decrease) in Accounts Payable | $-1,473 | $-4,188 | $8,447 | $6,695 |
| Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | — | $-3,942 | $-8,097 | $-552 |
| Increase (Decrease) in Contract with Customer, Liability | — | $23,927 | $-3,816 | $-3,847 |